The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy devices. However, lack of reimbursement, cost constraints, and the impact of COVID-19 pandemic will limit market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the Asia Pacific region across a 10-year period.

The COVID-19 pandemic will have a negative impact on overall PV procedures and revenues in 2020.

What factors will contribute to the impact on PV device market?

To what degree will the pandemic affect different PV device segments?

How soon will procedure volumes, sales, and revenues recover over the forecast period?

A meta-analysis was published in 2018 that showed an increased risk of death associated with paclitaxel-coated balloons and stents after 2 years.

How has this study impacted the Asia Pacific markets for DCBs and DES?

How has this study impacted physicians' perception of these products?

Which companies will be affected and how?

Budgetary constraints continue to affect the Asia Pacific PV device market, especially in China and India.

How fast will ASPs erode and which countries will experience the greatest erosion?

How do the reimbursement landscapes differ in the Asia Pacific countries?

How can companies mitigate downward pressure in pricing?

DCBs and DES manufacturers have invested in clinical trials to expand their offerings in indications such as BTK.

Which trials will impact the adoption of DCBs and DES for the BTK indication?

What has been physicians' preferred approach to treat lesions in the BTK indication?

Although most segments in the Asia Pacific PV device market are dominated by large international manufacturers, local players are increasing their product offerings.

Which companies lead each of the PV device segments?

Which countries and segments will have highest competition from local players?

What competitive strategies can firms use to maintain and/or improve their competitive positions going forward?

Table of contents

  • Peripheral Vascular Devices - Market Insights - Asia Pacific

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.

Follow Bishwjit on twitter: @Bishwjit_DRG